Author: Emma Yasinski

Emma Yasinski

I am a freelance science and medical journalist, fascinated by how the scientific process leads to incredible discoveries, but also can lead to publication bias leaning toward positive findings and minimizing negatives. With a bachelor’s degree in neuroscience from Lafayette College and a Master’s in Science and Medical Journalism from Boston University, I’ve written about clinical trial transparency, organ donation, and basic molecular biology for publications like The Scientist, The Atlantic, Undark.org, Kaiser Health News, and more. At MedShadow, I research and write about the sometimes unexpected ways that medicines can affect us, and what we can do if and when it does.

A now world-wide outbreak of hepatitis ‘that began in fall 2021 among young children, sickening hundreds, continues nearly eight months later, as of May 2022. The medical community is searching for its cause.  Some researchers believe it may have been triggered by COVID-19 infections or by colds or other viruses. The challenge is that the term hepatitis denotes an inflammation of the liver, but in order to treat it, a doctor needs to know what caused that inflammation. That’s problematic, because a doctor must know the cause to treat it effectively. Here’s what you need to know about the many…

Read More

Shingles is not your average rash. The painful, itchy red stripe caused by shingles can last up to 10 days, while long-term nerve pain, a common complication, can persist for months or years. In the rare event that the outbreak appears on your face, it can even cause blindness. Luckily, there’s a two-dose vaccine, Shingrix (zoster vaccine recombinant, adjuvanted), that can prevent the disease. It’s recommended for people 50 years and older, even if you’ve already had shingles, and those 19 and older who are immunosuppressed. Shingles is a unique disease in that it’s not caused by a new infection.…

Read More